Literature DB >> 19558374

Intermittent preventive treatment of malaria in infants: how does it work and where will it work?

R D Gosling1, I Carneiro, D Chandramohan.   

Abstract

We discuss the potential public health impact of IPTi by estimating the cases of malaria, anaemia and hospital admissions likely to be averted in different transmission settings; and we review the mechanism of action, choice of drugs regimens, and the effect on immunity of IPTi. IPTi using an efficacious drug is likely to substantially reduce cases of clinical malaria in moderate to high transmission settings. However, geographical heterogeneity in malaria transmission could hamper rolling out IPTi as a national policy.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19558374     DOI： 10.1111/j.1365-3156.2009.02303.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN： 1360-2276            Impact factor:   2.622


  7 in total

1.  Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children.

Authors:  Denis Boulanger; Jean Biram Sarr; Florie Fillol; Cheikh Sokhna; Badara Cisse; Anne-Marie Schacht; Jean-François Trape; Gilles Riveau; François Simondon; Brian Greenwood; Franck Remoué
Journal:  Malar J       Date:  2010-12-17       Impact factor: 2.979

2.  Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.

Authors:  Maroya D Spalding; Fredrick L Eyase; Hoseah M Akala; Sheryl A Bedno; Sean T Prigge; Rodney L Coldren; William J Moss; Norman C Waters
Journal:  Malar J       Date:  2010-11-24       Impact factor: 2.979

3.  Evaluating the effectiveness of IPTi on malaria using routine health information from sentinel health centres in southern Tanzania.

Authors:  Barbara A Willey; Joanna R M Armstrong Schellenberg; Werner Maokola; Kizito Shirima; Mwajuma Chemba; Hassan Mshinda; Pedro Alonso; Marcel Tanner; David Schellenberg
Journal:  Malar J       Date:  2011-02-14       Impact factor: 2.979

Review 4.  Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy.

Authors:  Julie Gutman; S Patrick Kachur; Laurence Slutsker; Alexis Nzila; Theonest Mutabingwa
Journal:  Malar J       Date:  2012-02-09       Impact factor: 2.979

5.  Adherence to intermittent preventive treatment for malaria in Papua New Guinean infants: A pharmacological study alongside the randomized controlled trial.

Authors:  Oriane Sottas; Monia Guidi; Benjamin Thieffry; Marie Schneider; Laurent Décosterd; Ivo Mueller; Blaise Genton; Chantal Csajka; Nicolas Senn
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

6.  Cost implications of improving malaria diagnosis: findings from north-eastern Tanzania.

Authors:  Jacklin F Mosha; Lesong Conteh; Fabrizio Tediosi; Samwel Gesase; Jane Bruce; Daniel Chandramohan; Roly Gosling
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

7.  Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H.

Authors:  M Andreína Pacheco; Kristan A Schneider; Qiuying Cheng; Elly O Munde; Caroline Ndege; Clinton Onyango; Evans Raballah; Samuel B Anyona; Collins Ouma; Douglas J Perkins; Ananias A Escalante
Journal:  Malar J       Date:  2020-10-22       Impact factor: 2.979
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.